$0.6220
-0.036-5.47%
Last update: Oct 30, 5:28 PM
Filana Therapeutics Inc (FLNA) Stock Price, Quote, News & History
FLNANASDAQ
The FDA lifted a clinical hold on Filana Therapeutics' IND application, allowing a Phase 2a trial for a TSC-related epilepsy treatment.
You can purchase shares of Filana Therapeutics (NASDAQ:FLNA) through any online brokerage.
Other companies in Filana Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Filana Therapeutics has a consensus price target of $5.00.
The stock price for Filana Therapeutics (NASDAQ: FLNA) is $0.6344 last updated October 30, 2026 at 5:28 PM EDT.
There are no upcoming dividends for Filana Therapeutics.
Filana Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Filana Therapeutics.
Filana Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related...
